 The study will enroll a total of 78 participants from Childrens Hospital of Philadelphia CHOP and from several other Cystic Fibrosis Centers. One half of the participants will be randomly picked to receive the active powder with the LYM-X-SORBTM supplement and one half will receive a placebo with no active supplement. 